Letter to the Editor-Active Surveillance for Biopsy Proven Renal Oncocytomas: Outcomes and Feasibility

We welcome this contribution to the growing body of evidence demonstrating the safety of active surveillance (AS) for biopsy-proven renal oncocytomas. The low median growth rate of 2.4 mm/year reported in this work is in keeping with our own series1 and that of others,2,3 in which no patient has developed metastases or disease-related mortality during median follow up of 29-34 months.
Source: Urology - Category: Urology & Nephrology Authors: Tags: Letters from the editor Source Type: research